US Patent 10774070 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
Patent 10774070 was granted and assigned to Blueprint Medicines on September, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 20, 2018
Date of Patent
September 15, 2020
Patent Applicant
Patent Application Number
16228381
Patent Citations
•••
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10774070 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
